Tech Company Financing Transactions
Notable Funding Round
Dave Eisenberg Syndicate joined a $10 thousand funding round for Notable. The round was announced on 7/25/2017.
Transaction Overview
Company Name
Announced On
7/25/2017
Transaction Type
Online Capital
Online Capital
Online Capital
Amount
$10,000
Round
Undisclosed
Investors
Dave Eisenberg Syndicate (Dave Eisenberg)
Proceeds Purpose
Proceeds purposes were not disclosed. Transaction amount may include investment reservation only or amount actually remitted to company. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
320 Hatch Dr.
Foster City, CA 94404
USA
Foster City, CA 94404
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Notable Labs is a translationally focused drug development company that uses a clinically validated, automated compound sensitivity platform to identify and advance novel therapeutic candidates to dramatically reduce the cost and time of the traditional drug development process.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Matthew Silva
Chief Executive Officer
Laurie Heilmann
Chief Medical Officer
Hiroomi Tada
Chief Scientific Officer
Joseph Wagner
Vice President
Marianne Santaguida
VP - Engineering
Scott Patterson
Browse more venture capital transactions:
Prev: 7/25/2017: eFFECTOR Therapeutics venture capital transaction
Next: 7/25/2017: Hinge Health venture capital transaction
Share this article
News on VC Transactions
We record every notable VC transaction. All VC database entries on this site are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs